Stent delivery systems and methods for making and using stent delivery systems

Information

  • Patent Grant
  • 10849771
  • Patent Number
    10,849,771
  • Date Filed
    Wednesday, June 27, 2012
    12 years ago
  • Date Issued
    Tuesday, December 1, 2020
    4 years ago
Abstract
Stent delivery systems and methods for making and using stent delivery systems are disclosed. An example stent delivery system may include a guide catheter. A push catheter may be slidably disposed over the guide catheter. A stent may be slidably disposed over the guide catheter and disposed adjacent to a distal end of the push catheter. An attachment mechanism may be coupled to the push catheter that is configured to engage the stent. The attachment mechanism may include a base and at least one cantilever extending from the base.
Description
TECHNICAL FIELD

The present disclosure pertains to medical devices and methods for manufacturing medical devices. More particularly, the present disclosure pertains to stent delivery systems that include an attachment mechanism for securing a stent.


BACKGROUND

A wide variety of intracorporeal medical devices have been developed for medical use, for example, intravascular use. Some of these devices include guidewires, catheters, and the like. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices and methods, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices as well as alternative methods for manufacturing and using medical devices.


BRIEF SUMMARY

The invention provides design, material, manufacturing method, and use alternatives for medical devices. An example stent delivery system may include a guide catheter. A push catheter may be slidably disposed over the guide catheter. A stent may be slidably disposed over the guide catheter and disposed adjacent to a distal end of the push catheter. A cantilever may be coupled to the push catheter.


Another example stent delivery system may include a guide catheter. A push catheter may be slidably disposed over the guide catheter. A stent may be slidably disposed over the guide catheter and disposed adjacent to a distal end of the push catheter. The stent may have an opening formed therein. A beam may be attached to the push catheter. The beam may be configured to shift between a first engaged configuration where the beam is engaged with the opening in the stent and a second unengaged configuration.


An example method of delivering a stent within a body lumen of a patient may include providing a stent delivery system. The stent delivery system may include a guide catheter. A push catheter may be slidably disposed over the guide catheter. A stent may be slidably disposed over the guide catheter and disposed adjacent to a distal end of the push catheter. The stent having an opening formed therein. A beam may be attached to the push catheter. The beam is configured to shift between a first engaged configuration where the beam is engaged with the opening in the stent and a second unengaged configuration. The method may include advancing the stent delivery system through a body lumen to a position adjacent to an area of interest. The method may include proximally retracting the guide catheter relative to the push catheter to shift the beam from the first configuration to the second configuration.


The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present invention. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.





BRIEF DESCRIPTION OF THE DRAWINGS

The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:



FIG. 1 is a side view of an example stent delivery system;



FIG. 2 is a partial cross-sectional side view of the example stent delivery system of FIG. 1;



FIG. 3 is a perspective view of an example attachment mechanism;



FIG. 4 is a cross-sectional side view of an example stent delivery system with the attachment mechanism in a locked configuration;



FIG. 5 is a cross-sectional side view of an example stent delivery system with the attachment mechanism in a locked configuration;



FIG. 6 is a cross-sectional side view of an example stent delivery system with the attachment mechanism in a locked configuration; and



FIG. 7 is a perspective view of another example attachment mechanism.





While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.


DETAILED DESCRIPTION

For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.


All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.


The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).


As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.


The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.


A wide variety of biliary, endoscopic, and/or endosurgical procedures have been developed for making medical treatments, diagnoses, and images of areas along the biliary tract and/or the pancreatic tract. For the purposes of this disclosure, the “biliary tract” and/or the “pancreatic tract” are understood to include various components of the digestive system and include, for example, the various ducts of the biliary tree between the liver and the duodenum as well as the various ducts between the pancreas and the duodenum. Numerous endoscopic and/or endosurgical devices have been developed for making medical treatments, diagnoses, and images of areas along the biliary and pancreatic tracts. Some of these device and/or procedures include biliary catheters, biliary guidewires, biliary stent delivery systems, drainage of the bile duct, splinting of the bile duct during healing, providing bile duct patency in a stricture or past a stone, and the like. In general, these devices are guided to the biliary and/or pancreatic tract by an endoscope (and/or a duodenoscope) that is disposed in the duodenum. Once positioned, various interventions can be performed depending on the needs of the patient and the type of device utilized. Other locations and/or uses are also contemplated for the systems disclosed herein including, for example, urinary tract interventions and/or urological interventions, gynecological interventions, etc.


When delivering a stent such as a drainage stent to the appropriate position within the anatomy, it may be desirable to hold or secure the position of the stent relative to a push catheter, which may be part of the stent delivery system. This allows the clinician to position and deploy the stent accurately at the intended location. One way that the stent may be secured to the push catheter may be with the use of a suture. Conventionally when a suture is utilized to secure a stent to a push catheter, the suture is formed into a loop that is wrapped around the guide catheter (which may extend through the lumen of the push catheter). The suture then extends through one of the barbed openings or flaps formed in the stent and it may be pulled snugly and attached or tied to the end of the push catheter, for example at a hole or opening formed at the distal end of the push catheter. As long as the position of the guide catheter is held stationary relative to the push catheter, this arrangement holds the position of the stent and effectively secures the stent to the push catheter. To release the stent, the guide catheter can be proximally retracted to a point where it exits and is disposed proximally of the loop formed in the suture. When no longer wrapped around the guide catheter, the loop or looped end of the suture is free to simply exit the opening at the barbed flap of the stent such that the stent is released from the push catheter.


Disclosed herein are a number of delivery systems for delivering a stent (e.g., a drainage stent) to an appropriate position within the anatomy. The delivery systems may use an attachment mechanism to secure the position of the stent relative to a push member or catheter. The attachment mechanism may allow a clinician to selectively “lock” and “unlock” a stent to the push catheter so that the stent can be accurately deployed to a target site. The use of the attachment mechanism disclosed herein may be desirable for a number of reasons. For example, the attachment mechanism disclosed herein allows the deployment of a stent while the guidewire is left in place. This allows the clinician to maintain guidewire access within the anatomy throughout the intervention. In addition, the attachment mechanism disclosed herein may allow a clinician to deploy and/or reposition the stent multiple times with just one system. Additionally, the attachment mechanism may be formed from materials that allow for improved visualization at the treatment including radiopaque materials. Moreover, the attachment mechanism disclosed herein may help control or otherwise fix the distance between the push catheter and the stent, which may increase the accuracy in deployment. Furthermore, the attachment mechanism disclosed herein may eliminate the need for sutures, which may be expensive and labor intensive to use. In addition, manufacturing the attachment mechanism disclosed herein (and/or the delivery systems incorporating the attachment mechanism) may be possible in an automated or semi-automated manner so that manufacturing costs can be reduced. These are just examples. Some additional details regarding these and other features are provided below.


Referring now to FIGS. 1 and 2, there is shown an example medical device, illustrated as a delivery system 10 for delivering, for example, a stent 20 such as a drainage stent to a suitable target location such as, for example, a target along the biliary and/or pancreatic tree. The system 10 may also be used at any other suitable location. The stent 20 may be used to bypass or drain an obstructed lumen, for example along the biliary and/or pancreatic tree, and can be configured for long-term positioning within the body. It should be understood that the terms “drainage stent”, “drainage catheter” and “stent” can be used interchangeably with reference to the devices and systems disclosed herein.


The delivery system 10 may be designed for use with a conventional guidewire 2 and may include a guide catheter 12, a delivery or push catheter 14, and a handle assembly 16. The guidewire 2 may extend into a lumen 22 of the guide catheter 12, through a distal guidewire port 24, and out a proximal guidewire port 26 formed in a sidewall of the push catheter 14, providing the delivery system 10 with single-operator-exchange (SOE) capabilities. Other embodiments are also contemplated, however, where the delivery system 10 is an over-the-wire (OTW) system.


The guide catheter 12 may be slidably disposed within the lumen 28 of the push catheter 14 and may extend distally from the distal end of the push catheter 14. The stent 20 may be positioned on a distal portion of the guide catheter 12, which may be located distal of the push catheter 14, and the stent 20 may abut or otherwise be disposed adjacent to the distal end 30 of the push catheter 14. When the stent 20 has been properly placed, the stent 20 may be disconnected from the push catheter 14 such that the stent 20 remains in the anatomy or body lumen when the push catheter 14 is withdrawn.


The proximal end 32 of the push catheter 14 may be attached to the handle assembly 16. For example, the proximal end 32 may include a female luer lock connector 34 threadably coupled to a threaded male connector 36 of the handle assembly 16. It may be understood, however, that the push catheter 14 may be attached to the handle assembly 16 and extend distally therefrom by other means, such as adhesive bonding, welding, friction fit, interlocking fit, or other suitable means.


The guide catheter 12 may include a distal tubular portion 38 and a proximal elongate wire 40, such as a pull wire, coupled to the distal tubular portion 38. In some instances, the elongate wire 40 may be a wire, filament, thread, portion of a catheter wall, fabric, web, or similar elongate structure. The elongate wire 40 may be coupled to the distal tubular portion 38 at a rotatable connection that may allow rotatable movement between the tubular portion 38 and the elongate wire 40 of the guide catheter 12. The elongate wire 40 may extend through the lumen 28 of the push catheter 14 to the handle assembly 16. In some embodiments, the elongate wire 40 may extend through the handle assembly 16 to a location proximal of the handle assembly 16. The proximal end of elongate wire 40 may terminate at a knob 42 which may be grasped by an operator to manipulate the guide catheter 12.


As shown in FIG. 2, the elongate wire 40 may share the lumen 28 of the push catheter 14 with the guidewire 2 along a portion of the length of the elongate wire 40. Thus, a portion of the elongate wire 40 may extend proximally from the tubular portion 38 along the side of the guidewire 2 through the lumen 28 of the push catheter 14 up to a location where the guidewire 2 exits the proximal guidewire port 26 of the push catheter 14.


The stent 20 may include one or more anchors 46 that are generally disposed near an opening 50 in the stent 20. Anchors 46, for example, may project radially outward from the stent 20 and help to secure or “anchor” the position of the stent 20 within the anatomy when deployed. In at least some embodiments, the anchors 46 are defined by a skived cut in the stent 20 and take the form of a barb or barb-like flap. Other configurations are contemplated.


As indicated above, the system 10 may also include an attachment mechanism 44. In general, the attachment mechanism may be configured to secure the position of the stent 20 relative to the push catheter 14. To do so, the attachment mechanism 44 may have a portion that extends through a hole or opening 45 formed in the stent 20. Note that in some cases, the hole or opening 45 may be positioned proximally from the barb openings 50 in the stent 20. In other embodiments, however, the attachment mechanism 44 may engage one of the barb openings 50, thereby reducing or eliminating the need for dedicated openings 45. In some embodiments, the hole 45 extends through the wall of the stent 20 while in others the hole 45 may extend through only a portion of the wall of the stent 20 or otherwise take the form of a groove.


The example attachment mechanism 44 may include a generally cylindrical base 52 and a beam or cantilever 54 extending from the base 52 as shown in FIG. 3. The length of the cantilever 54 extending from the base 52 may vary. For example, attachment mechanisms 44 are contemplated where the length of the cantilever 54 is relatively short as compared to the base 52 (e.g., the length is only a portion of the length of the base 52) and other attachment mechanisms are contemplated where the length of the cantilever 54 approximates or approaches the length of the base 52. In at least some embodiments, the base 52 may be disposed between the guide catheter 12 and the push catheter 14. For example, the base 52 may be attached to the push catheter 14. To facilitate bonding between the base 52 and the push catheter 14, the base 52 may include one or more retention holes 56. For example, the push catheter 14 may be molded into the retention holes 56 in the attachment mechanism 44 to create a bond between the push catheter 14 and the attachment mechanism 44. Alternatively, the attachment mechanism 44 may be attached to the push catheter 14 by an adhesive, by welding or soldering, by a thermal bond, or using any other suitable manner. In some cases, the attachment mechanism 44 may be modified to further enhance the bond to the push catheter 14 by applying an abrasive finish, a ribbed surface, a barbed surface, a threaded surface or surfaces, a snap-in mechanism such as a matching groove and bumps, or by creating an interference fit between the inner diameter of the push catheter 14 and the outer diameter of the cylindrical base 52 of the attachment mechanism 44. These are just examples.


Note that in some cases, the attachment mechanism 44 may be omitted completely. In at least some of these cases, a cantilever or beam (e.g., which may be similar to the cantilever 54) may extend from the stent 20 toward the guide catheter 12, or may extend from the guide catheter 12 toward the stent 20, without the use of an attachment mechanism 44. In some cases, the cantilever or beam may be a wire with an upward bend.


The attachment mechanism 44 may be formed in any suitable manner. For example, the attachment mechanism 44 may be formed from a metal tube or cannula that is cut by punch and die tooling, laser cutting, electron discharge machining, or other suitable techniques. Alternatively, the attachment mechanism may be thermoformed by injection molding. These are just examples as other forming techniques are contemplated.


The size, shape, and/or configuration of the attachment mechanism 44 may also improve the accuracy of stent 20 deployment. For example, because the cantilever 54 may have an essentially constant length and because the base 52 may be fixed to the push catheter 14, the precise position of the stent 20 relative to the push catheter 14 may be known. This controls the distance between the stent 20 and the push catheter 14 using the dimensionally controlled cantilever 54. Because of this, the clinician may be able to reliably determine where the stent 20 is located based on the position of the push catheter 14. Moreover, if the attachment mechanism 44 includes a radiopaque material, fluoroscopic visualization may also be relied upon to accurately determine the position of the stent 20.


The cantilever 54 may have a fixed proximal end 58, which is fixed to the cylindrical base 52, and may have a free distal end 60 that extends away from the fixed proximal end 58. In this example, the cylindrical base 52 may include a longitudinal notch 62 extending proximally from a distal edge of the cylindrical base 52, with the cantilever 54 extending distally from a proximal edge of the notch 62. The base 52 may form a support wall that allows the stent 20 to be better aligned and supported by the attachment mechanism 44. The cantilever 54 may extend substantially parallel to a longitudinal axis of the guide catheter 12.


The cantilever 54 may be configured to shift between a first or “locked configuration” and a second or “unlocked” configuration. When in the locked configuration, the cantilever 54 may be oriented so that the distal end 60 projects into or otherwise engages the opening 45 in the stent 20 such that the stent 20 is substantially “locked” or otherwise fixed to the push catheter 14. When in the unlocked configuration, the cantilever 54 shifts (e.g., radially inward) so that the distal end 60 disengages from the opening 45 in the stent 20 such that the stent 20 is no longer fixed to the push catheter 14.


The cantilever 54 may form a hinge or pivot point adjacent to the proximal end 58 that allows the cantilever 54 to move, for example, radially outward and inward. For example, the cantilever 54 may be pre-bent or curved radially inward. In at least some embodiments, the cantilever 54 may be biased to be in this pre-bent configuration. This may correspond to the unlocked configuration. The cantilever 54 may be shifted between the locked and unlocked configuration by the guide catheter 12. For example, when the guide catheter 12 is passed through the attachment mechanism 44, the guide catheter 12 may engage and urge radially outward the cantilever 54 and, thus, shifts it to the locked configuration as shown in FIG. 4. In other words, the cantilever 54 may be biased to be in the unlocked configuration and advancing the guide catheter 12 through the attachment mechanism 44 overcomes the bias. When in the locked configuration, the distal end 60 of the cantilever 54 may extend through the opening 45 of the stent 20. When the guide catheter 12 is retracted proximally, the guide catheter 12 no longer engages the cantilever 54 and the cantilever 54 may deflect radially inward and disengage from the opening 45 in the stent 20 as shown in FIG. 5. When the cantilever 54 is in the unlocked configuration, the stent 20 is released from the push catheter 14 and the stent 20 can be deployed as shown in FIG. 6.


Because the configuration of the cantilever 54 may be altered by movement of the guide catheter 12, the clinician may have control of the stent 20 and may be able to hold/secure the stent 20 and then release/deploy the stent 20 “on demand”. In addition, because shifting of the cantilever 54 is accomplished through movement of the guide catheter 12, the guidewire 2 can be left in place during deployment of the stent 20, which provides greater flexibility for the clinician because access to the appropriate location in the anatomy can be maintained throughout the intervention.


The attachment mechanism 44 may be made of any suitable materials including any of those disclosed herein. For example, the attachment mechanism 44 may be made from stainless steel, nitinol, tantalum, and tungsten. Alternatively, the attachment mechanism 44 may be made from a polymer including, for example, PEEK (polyetheretherketone), ABS (acrylonitrile-butadienestyrene), Nylon, Polyester, Ultem (PEI, or Polyether Imide), LCP (liquid crystal polymer), HDPE (high-density polyethylene) or LDPE (low-density polyethylene). These are just examples. In some cases, the attachment mechanism 44 may be made of or otherwise include a radiopaque material that can be viewed under fluoroscopy to aid in properly placing the stent 20.



FIG. 7 is a perspective view of another example attachment mechanism 144, which may be similar in form and function to the attachment mechanism 44, and may be utilized with the delivery system 10. The attachment mechanism 144 includes a cylindrical base 152 and retention holes 156. In this example, rather than being disposed within a notch in the base 152, the cantilever or beam extends distally from the base 152. For example, the proximal end 158 is attached or fixed to the base 152 and projects distally therefrom. This may increase the flexibility of the attachment mechanism 144 and, thus, the delivery system that it is incorporated into. The distal end 160 of the cantilever 154 may engage the opening 45 of the stent 20 in a manner similar to how the distal end 60 of the attachment mechanism 44 does.


In the examples disclosed herein, the attachment mechanisms 44/144 only include one cantilever or beam 54/154. This, however, is not intended to be limiting. Embodiments are contemplated where the attachment mechanism 44/144 includes more than one cantilever 54/154. For example, the attachment mechanism 44/144 may include two, three, four, five, six, or more cantilevers 54/154 arranged in any suitable manner. In these embodiments, the stent 20 may also include corresponding openings (e.g., similar to opening 45) for each of the cantilevers. In some cases, more than one cantilever may lock into the same hole or opening (e.g., the opening 45) in the stent 20. In some cases, the inclusion of two opposing cantilevers may allow the delivery system 10 to be used as a grasping device to remove and/or reposition stent 20. In addition, the distal end 60/160 of the cantilevers 54/154 may include a projection that projects radially inward, which may further improve the ability of the cantilevers 54/154 to remove and/or reposition the stent 20.


Note that cantilever 54 is not required to have any particular width or thickness. However, the geometry and material of cantilever 54 may be chosen to control the release of the stent 20. End 60 is not limited to the tab as shown. For instance, the end 60 may be a peg or bump, or may include more than one tab or peg.


In some cases, the cantilever may not be a solid element or beam, but may include one or more hollow portions that extend through the cantilever. For instance, the cantilever may include one or more holes that extend vertically through the cantilever. In some cases, the cantilever may be formed as a wire, extending longitudinally from the attachment mechanism, forming a loop that extends laterally and also extends vertically so that the vertical portion can engage the hole or groove in the stent, and then extends longitudinally to attach at its opposite end at the attachment mechanism. For these cases, the attachment points may be relatively close together so that the longitudinally extending portions are generally parallel, or may be relatively far apart so that the longitudinally extending portions include a lateral component. In other cases, the cantilever may be formed as a single wire that is only affixed to the attachment mechanism at one end, where the other end terminates at or near an upward-extending hook. These are just examples.


In some cases, the aspect ratio of the beam or cantilever 54 may be relatively close to 1:1, or may even include a larger width than length.


In some cases, the mating hole in the stent 20 may not extend fully through the stent 20, or may be formed as a groove rather than a hole.


As alluded to herein, the delivery system 10 and/or components thereof may be made from a metal, metal alloy, polymer (some examples of which are disclosed below), a metal-polymer composite, ceramics, combinations thereof, and the like, or other suitable material. Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: N06625 such as INCONEL® 625, UNS: N06022 such as HASTELLOY® C-22®, UNS: N10276 such as HASTELLOY® C276®, other HASTELLOY® alloys, and the like), nickel-copper alloys (e.g., UNS: N04400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nickel-molybdenum alloys (e.g., UNS: N10665 such as HASTELLOY® ALLOY B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like); platinum enriched stainless steel; titanium; combinations thereof; and the like; or any other suitable material.


Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane (for example, Polyurethane 85A), polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), poly(styrene-b-isobutylene-b-styrene) (for example, SIBS and/or SIBS 50A), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments the polymer can be blended with a liquid crystal polymer (LCP). For example, the mixture can contain up to about 6 percent LCP.


In at least some embodiments, portions or all of the tubular member(s) may also be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of tubular member in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like. Additionally, other radiopaque marker bands and/or coils may also be incorporated into the design of the tubular member to achieve the same result.


In some embodiments, a degree of Magnetic Resonance Imaging (MRI) compatibility is imparted into the tubular member. For example, the tubular member, or portions thereof, may be made of a material that does not substantially distort the image and create substantial artifacts (i.e., gaps in the image). Certain ferromagnetic materials, for example, may not be suitable because they may create artifacts in an MRI image. The tubular member, or portions thereof, may also be made from a material that the MRI machine can image. Some materials that exhibit these characteristics include, for example, tungsten, cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nitinol, and the like, and others.


In some embodiments, a coating, for example a lubricious, a hydrophilic, a protective, or other type of coating may be applied over portions or all of the delivery system or components thereof. Hydrophobic coatings such as fluoropolymers provide a dry lubricity which improves device handling and device exchanges. Lubricious coatings improve steerability and improve lesion crossing capability. Suitable lubricious polymers are well known in the art and may include silicone and the like, hydrophilic polymers such as high-density polyethylene (HDPE), polytetrafluoroethylene (PTFE), polyarylene oxides, polyvinylpyrolidones, polyvinylalcohols, hydroxy alkyl cellulosics, algins, saccharides, caprolactones, and the like, and mixtures and combinations thereof. Hydrophilic polymers may be blended among themselves or with formulated amounts of water insoluble compounds (including some polymers) to yield coatings with suitable lubricity, bonding, and solubility. Some other examples of such coatings and materials and methods used to create such coatings can be found in U.S. Pat. Nos. 6,139,510 and 5,772,609, which are incorporated herein by reference.


The arrangement of the various structures of the delivery system 10 may vary. In some embodiments, the system 10 may include any of the structures or utilize any of the arrangements of structures that are disclosed in U.S. Pat. Nos. 5,152,749; 5,334,185; 5,921,952; 6,248,100; 6,264,624; and 6,562,024, the entire disclosures of which are herein incorporated by reference. In addition, U.S. Patent Application Ser. No. 61/415,660, filed Nov. 19, 2010, is also herein incorporated by reference.


It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.

Claims
  • 1. A stent delivery system, comprising: a guide catheter;a push catheter slidably disposed over the guide catheter;a stent slidably disposed over the guide catheter and disposed adjacent to a distal end of the push catheter, the stent having an opening formed therein;a cylindrical member disposed between the guide catheter and push catheter, the cylindrical member having a longitudinal notch formed therein; anda cantilever disposed within the longitudinal notch, wherein the cantilever includes a proximal end fixed to the cylindrical member and a free distal end extending from the fixed proximal end, wherein the free distal end is configured to project into the stent opening.
  • 2. The stent delivery system of claim 1, wherein the cantilever is configured to shift between a first secured configuration where the cantilever is engaged with the stent to secure the stent to the push catheter and a second unsecured configuration.
  • 3. The stent delivery system of claim 2, wherein the cantilever is biased to be in the second configuration.
  • 4. The stent delivery system of claim 2, wherein the cantilever is in the first configuration when the guide catheter extends through the push catheter.
  • 5. The stent delivery system of claim 4, wherein the cantilever shifts from the first configuration to the second configuration when the guide catheter is withdrawn proximally relative to the push catheter.
  • 6. The stent delivery system of claim 1, wherein the stent is a drainage stent.
  • 7. The stent delivery system of claim 1, wherein the stent has at least one flap or barb formed therein.
  • 8. The stent delivery system of claim 1, wherein the cantilever includes a radiopaque material.
  • 9. The stent delivery system of claim 1, wherein the cylindrical member is attached to the push catheter.
  • 10. A stent delivery system, comprising: a guide catheter;a push catheter slidably disposed over the guide catheter;a stent slidably disposed over the guide catheter and disposed adjacent to a distal end of the push catheter, the stent having an opening formed therein;a cylindrical member disposed between the guide catheter and push catheter, the cylindrical member having a longitudinal notch formed therein; anda beam is disposed within the longitudinal notch, wherein the beam includes a proximal end fixed to cylindrical member and a free distal end extending from the fixed proximal end, wherein the beam is configured to shift between a first engaged configuration where the free distal end projects into the opening in the stent and a second unengaged configuration.
  • 11. The stent delivery system of claim 10, wherein the beam is biased to be in the second configuration.
  • 12. The stent delivery system of claim 10, wherein the beam is in the first configuration when the guide catheter extends through the push catheter.
  • 13. The stent delivery system of claim 12, wherein the beam shifts from the first configuration to the second configuration when the guide catheter is withdrawn proximally relative to the push catheter.
  • 14. The stent delivery system of claim 10, wherein the cylindrical member is attached to the push catheter.
  • 15. A method of delivering a stent within a body lumen of a patient, comprising: advancing a stent delivery system through a body lumen to a position adjacent to an area of interest, the stent delivery system comprising: a guide catheter,a push catheter slidably disposed over the guide catheter,a stent slidably disposed over the guide catheter and disposed adjacent to a distal end of the push catheter, the stent having an opening formed therein,a cylindrical member disposed between the guide catheter and push catheter, the cylindrical member having a longitudinal notch formed therein, anda beam disposed within the longitudinal notch, wherein the beam includes a proximal end fixed to the cylindrical member and a free distal end extending from the proximal end, wherein the beam is configured to shift between a first engaged configuration where the free distal end projects into the opening in the stent and a second unengaged configuration; andproximally retracting the guide catheter relative to the push catheter to shift the beam from the first configuration to the second configuration.
  • 16. The method of claim 15, wherein advancing the stent delivery system through a body lumen to a position adjacent to an area of interest includes advancing the stent delivery system while the beam is in the first configuration.
  • 17. The method of claim 15, wherein the beam secures the stent to the push catheter when the beam is in the first configuration and wherein proximally retracting the guide catheter releases the stent from the push catheter.
  • 18. The method of claim 15, further comprising advancing the guide catheter distally to shift the beam from the second configuration to the first configuration.
  • 19. The method of claim 15, wherein the cylindrical member is attached to the push catheter.
CROSS-REFERENCE TO RELATED APPLICATION

This application claims priority under 35 U.S.C. § 119 to U.S. Provisional Application Ser. No. 61/501,387, filed Jun. 27, 2011, the entirety of which is incorporated herein by reference.

US Referenced Citations (357)
Number Name Date Kind
1204053 Moore Nov 1916 A
2212334 Wallerich Aug 1940 A
2393003 Smith Jan 1946 A
2623520 Bamford, Jr. et al. Dec 1952 A
3015869 Rapata Jan 1962 A
3100490 Desautels Aug 1963 A
3332424 Minteer Jul 1967 A
3421509 Fiore Jan 1969 A
3460541 Doherty Aug 1969 A
3536281 Meehan et al. Oct 1970 A
3592197 Cohen Jul 1971 A
3707151 Jackson Dec 1972 A
3783453 Bolie Jan 1974 A
3889686 Duturbure Jun 1975 A
3890977 Wilson Jun 1975 A
3908635 Viek Sep 1975 A
3938529 Gibbons Feb 1976 A
3970089 Saice Jul 1976 A
3995642 Adair Dec 1976 A
4194513 Rhine et al. Mar 1980 A
4212304 Finney Jul 1980 A
4225979 Rey et al. Oct 1980 A
4242304 Ryder Dec 1980 A
4248214 Hannah et al. Feb 1981 A
4299226 Banka Nov 1981 A
4307723 Finney Dec 1981 A
4334327 Lyman et al. Jun 1982 A
4345606 Littleford Aug 1982 A
4364392 Strother et al. Dec 1982 A
4382445 Sommers May 1983 A
4411654 Boarini et al. Oct 1983 A
4412832 Kling et al. Nov 1983 A
4413989 Schjeldahl et al. Nov 1983 A
4423725 Baran et al. Jan 1984 A
4425919 Alston, Jr. et al. Jan 1984 A
4434797 Silander Mar 1984 A
4445892 Hussein et al. May 1984 A
4474569 Newkirk Oct 1984 A
4484585 Baier Nov 1984 A
4500313 Young Feb 1985 A
RE31855 Osborne Mar 1985 E
4531933 Norton et al. Jul 1985 A
4545373 Christoudias Oct 1985 A
4554929 Samson et al. Nov 1985 A
4568338 Todd Feb 1986 A
4573470 Samson et al. Mar 1986 A
4581017 Sahota Apr 1986 A
4582181 Samson Apr 1986 A
4592341 Omagari et al. Jun 1986 A
4606347 Fogarty et al. Aug 1986 A
4610657 Densow Sep 1986 A
4616653 Samson et al. Oct 1986 A
4641654 Samson et al. Feb 1987 A
4643716 Drach Feb 1987 A
4645493 Ferrando et al. Feb 1987 A
4646742 Packard et al. Mar 1987 A
4654025 Cassou et al. Mar 1987 A
4655746 Daniels et al. Apr 1987 A
4655771 Wallsten Apr 1987 A
4671795 Mulchin Jun 1987 A
4684369 Wildemeersch Aug 1987 A
4696668 Wilcox Sep 1987 A
4699611 Bowden Oct 1987 A
4713049 Carter Dec 1987 A
4723550 Bales et al. Feb 1988 A
4738667 Galloway Apr 1988 A
4747833 Kousai et al. May 1988 A
4748982 Horzewski et al. Jun 1988 A
4755175 Nilsson Jul 1988 A
4762128 Rosenbluth Aug 1988 A
4762129 Bonzel Aug 1988 A
4763654 Jang Aug 1988 A
4771777 Horzewski et al. Sep 1988 A
4781677 Wilcox Nov 1988 A
4783454 Liu Nov 1988 A
4784651 Hickey Nov 1988 A
4787884 Goldberg Nov 1988 A
4790315 Mueller, Jr. et al. Dec 1988 A
4790809 Kuntz Dec 1988 A
4790810 Pugh, Jr. et al. Dec 1988 A
4798193 Giesy et al. Jan 1989 A
4798594 Hillstead Jan 1989 A
4813925 Anderson, Jr. et al. Mar 1989 A
4813934 Engelson et al. Mar 1989 A
4817613 Jaraczewski et al. Apr 1989 A
4819751 Shimada et al. Apr 1989 A
4820262 Finney Apr 1989 A
4822333 Lavarenne Apr 1989 A
4824435 Giesy et al. Apr 1989 A
4832055 Palestrant May 1989 A
4835824 Durham et al. Jun 1989 A
4838268 Keith et al. Jun 1989 A
4844092 Rydell et al. Jul 1989 A
4846174 Willard et al. Jul 1989 A
4846193 Tremulis et al. Jul 1989 A
4848343 Wallsten et al. Jul 1989 A
4848344 Sos et al. Jul 1989 A
4874360 Goldberg et al. Oct 1989 A
4877031 Conway et al. Oct 1989 A
4886065 Collins, Jr. Dec 1989 A
4892519 Songer et al. Jan 1990 A
4898577 Badger et al. Feb 1990 A
4900184 Cleveland Feb 1990 A
4905667 Foerster et al. Mar 1990 A
4906241 Noddin et al. Mar 1990 A
4913141 Hillstead Apr 1990 A
4913683 Gregory Apr 1990 A
4917088 Crittenden Apr 1990 A
4917103 Gambale et al. Apr 1990 A
4917666 Solar et al. Apr 1990 A
4927418 Dake et al. May 1990 A
4928693 Goodin et al. May 1990 A
4931037 Wetterman Jun 1990 A
4932413 Shockey et al. Jun 1990 A
4932959 Horzewski et al. Jun 1990 A
4944745 Sogard et al. Jul 1990 A
4946443 Hauser et al. Aug 1990 A
4950228 Knapp, Jr. et al. Aug 1990 A
4955858 Drews Sep 1990 A
4955895 Sugiyama et al. Sep 1990 A
4957479 Roemer Sep 1990 A
4963129 Rusch Oct 1990 A
4964409 Tremulis Oct 1990 A
4967753 Haase et al. Nov 1990 A
4973301 Nissenkorn Nov 1990 A
4976720 Machold et al. Dec 1990 A
4983168 Moorehead Jan 1991 A
4986814 Burney et al. Jan 1991 A
4988356 Crittenden et al. Jan 1991 A
4990133 Solazzo Feb 1991 A
4990151 Wallsten Feb 1991 A
4994027 Farrell Feb 1991 A
4994066 Voss Feb 1991 A
4997421 Palsrok et al. Mar 1991 A
4998917 Gaiser et al. Mar 1991 A
4998923 Samson et al. Mar 1991 A
5002532 Gaiser et al. Mar 1991 A
5003990 Osypka Apr 1991 A
5007901 Shields Apr 1991 A
5015231 Keith et al. May 1991 A
5019085 Hillstead May 1991 A
5019102 Hoene May 1991 A
5026377 Burton et al. Jun 1991 A
5026607 Kiezulas Jun 1991 A
5031636 Gambale et al. Jul 1991 A
5032113 Burns Jul 1991 A
5035705 Burns Jul 1991 A
5040548 Yock Aug 1991 A
5042985 Elliott et al. Aug 1991 A
5045061 Seifert et al. Sep 1991 A
5046497 Millar Sep 1991 A
5047018 Gay et al. Sep 1991 A
5047045 Arney et al. Sep 1991 A
5052998 Zimmon Oct 1991 A
5057092 Webster, Jr. Oct 1991 A
5061267 Zeiher Oct 1991 A
5061273 Yock Oct 1991 A
5064414 Revane Nov 1991 A
5066285 Hillstead Nov 1991 A
5078681 Kawashima Jan 1992 A
5085636 Burns Feb 1992 A
5090958 Sahota Feb 1992 A
5098374 Othel-Jacobsen et al. Mar 1992 A
5114403 Clarke et al. May 1992 A
5116309 Coll May 1992 A
5120308 Hess Jun 1992 A
5125905 Wright et al. Jun 1992 A
5125915 Berry et al. Jun 1992 A
5135494 Engelson et al. Aug 1992 A
5135535 Kramer Aug 1992 A
5141502 Macaluso, Jr. Aug 1992 A
5141518 Hess et al. Aug 1992 A
5147370 McNamara et al. Sep 1992 A
5147377 Sahota Sep 1992 A
5152749 Giesy et al. Oct 1992 A
5154725 Leopold Oct 1992 A
5158545 Trudell et al. Oct 1992 A
5160321 Sahota Nov 1992 A
5160341 Brenneman et al. Nov 1992 A
5167634 Corrigan, Jr. et al. Dec 1992 A
5171221 Samson Dec 1992 A
5171222 Euteneuer et al. Dec 1992 A
5176637 Sagae Jan 1993 A
5180367 Kontos et al. Jan 1993 A
5181921 Makita et al. Jan 1993 A
5195978 Schiffer Mar 1993 A
5205822 Johnson et al. Apr 1993 A
5209728 Kraus et al. May 1993 A
5217434 Arney Jun 1993 A
5217482 Keith Jun 1993 A
5221260 Burns et al. Jun 1993 A
5232445 Bonzel Aug 1993 A
5234437 Sepetka Aug 1993 A
5242396 Evard Sep 1993 A
5248306 Clark et al. Sep 1993 A
5250033 Evans et al. Oct 1993 A
5250071 Palermo Oct 1993 A
5256144 Kraus et al. Oct 1993 A
5261916 Engelson Nov 1993 A
5267958 Buchbinder et al. Dec 1993 A
5277199 DuBois et al. Jan 1994 A
5279562 Sirhan et al. Jan 1994 A
5282479 Havran Feb 1994 A
5282784 Willard Feb 1994 A
5290232 Johnson et al. Mar 1994 A
5290241 Kraus et al. Mar 1994 A
5290247 Crittenden Mar 1994 A
5295954 Sachse Mar 1994 A
5300085 Yock Apr 1994 A
5304195 Twyford, Jr. et al. Apr 1994 A
5304198 Samson Apr 1994 A
5306247 Pfenninger Apr 1994 A
5308318 Plassche, Jr. May 1994 A
5320602 Karpiel Jun 1994 A
5320604 Walker et al. Jun 1994 A
5322501 Mahmud-Durrani Jun 1994 A
5324259 Taylor et al. Jun 1994 A
5324269 Miraki Jun 1994 A
5328468 Kaneko et al. Jul 1994 A
5334143 Carroll Aug 1994 A
5334185 Giesy et al. Aug 1994 A
5334187 Fischell et al. Aug 1994 A
5346467 Coll Sep 1994 A
5348537 Wiesner et al. Sep 1994 A
5350395 Yock Sep 1994 A
5354263 Coll Oct 1994 A
5360401 Turnland Nov 1994 A
5364340 Coll Nov 1994 A
5364354 Walker et al. Nov 1994 A
5364355 Alden et al. Nov 1994 A
5364376 Horzewski et al. Nov 1994 A
5370623 Kreamer Dec 1994 A
5370655 Burns Dec 1994 A
5372600 Beyar et al. Dec 1994 A
5382234 Cornelius et al. Jan 1995 A
5454790 Dubrul Jan 1995 A
5389087 Miraki Feb 1995 A
5391155 Sachse Feb 1995 A
5395335 Jang Mar 1995 A
5397302 Weaver et al. Mar 1995 A
5401257 Chevalier, Jr. et al. Mar 1995 A
5405378 Strecker Apr 1995 A
5407435 Sachse Apr 1995 A
5409468 Sachse Apr 1995 A
5425711 Ressemann et al. Jun 1995 A
5451233 Yock Sep 1995 A
5454788 Walker et al. Oct 1995 A
5456680 Taylor et al. Oct 1995 A
5458584 Ginn et al. Oct 1995 A
5458605 Klemm Oct 1995 A
5458613 Gharibadeh et al. Oct 1995 A
5458615 Klemm et al. Oct 1995 A
5470315 Adams Nov 1995 A
5476505 Limon Dec 1995 A
5480389 McWha et al. Jan 1996 A
5480434 Eckstein et al. Jan 1996 A
5484409 Atkinson et al. Jan 1996 A
5484444 Braunschweiler et al. Jan 1996 A
5489271 Andersen Feb 1996 A
5490837 Blaeser et al. Feb 1996 A
5496275 Sirhan et al. Mar 1996 A
5496344 Kanesaka et al. Mar 1996 A
5496346 Horzewski et al. Mar 1996 A
5501227 Yock Mar 1996 A
5507768 Lau et al. Apr 1996 A
5531700 Moore et al. Jul 1996 A
5533968 Muni et al. Jul 1996 A
5536248 Weaver et al. Jul 1996 A
5540236 Ginn Jul 1996 A
5545134 Hilaire et al. Aug 1996 A
5545138 Fugoso et al. Aug 1996 A
5549552 Peters et al. Aug 1996 A
5569201 Burns Oct 1996 A
5578009 Kraus et al. Nov 1996 A
5599291 Balbierz et al. Feb 1997 A
5599299 Weaver et al. Feb 1997 A
5599300 Weaver et al. Feb 1997 A
5626600 Horzewski et al. May 1997 A
5639274 Fischell et al. Jun 1997 A
5643278 Wijay Jul 1997 A
5645533 Blaeser et al. Jul 1997 A
5653748 Strecker Aug 1997 A
5669880 Solar Sep 1997 A
5676654 Ellis et al. Oct 1997 A
5681274 Perkins et al. Oct 1997 A
5690642 Osborne et al. Nov 1997 A
5690644 Yurek et al. Nov 1997 A
5693015 Walker et al. Dec 1997 A
5695468 Lafontaine et al. Dec 1997 A
5702439 Keith et al. Dec 1997 A
5706827 Ehr et al. Jan 1998 A
5709703 Lukic et al. Jan 1998 A
5725504 Collins Mar 1998 A
5743874 Fischell et al. Apr 1998 A
5772609 Nguyen et al. Jun 1998 A
5776099 Tremulis Jul 1998 A
5782855 Lau et al. Jul 1998 A
5788681 Weaver et al. Aug 1998 A
5800414 Cazal Sep 1998 A
5833706 St. Germain et al. Nov 1998 A
5843028 Weaver et al. Dec 1998 A
5849016 Suhr Dec 1998 A
5921952 Desmond, III et al. Jul 1999 A
5921971 Agro et al. Jul 1999 A
5947927 Mertens Sep 1999 A
5980533 Holman Nov 1999 A
6007522 Agro et al. Dec 1999 A
6059752 Segal May 2000 A
6077295 Limon et al. Jun 2000 A
6095990 Parodi Aug 2000 A
6096009 Windheuser et al. Aug 2000 A
6113607 Lau et al. Sep 2000 A
6139510 Palermo Oct 2000 A
6152910 Agro et al. Nov 2000 A
6159195 Ha et al. Dec 2000 A
6248100 de Toledo et al. Jun 2001 B1
6264624 Desmond, III et al. Jul 2001 B1
6309379 Willard et al. Oct 2001 B1
6346093 Allman et al. Feb 2002 B1
6380457 Yurek et al. Apr 2002 B1
6394141 Wages et al. May 2002 B2
6398799 Kramer Jun 2002 B2
6475187 Gerberding Nov 2002 B1
6488694 Lau et al. Dec 2002 B1
6527789 Lau et al. Mar 2003 B1
6562024 Alvarez de Toledo et al. May 2003 B2
6582401 Windheuser et al. Jun 2003 B1
6582459 Lau et al. Jun 2003 B1
6592549 Gerdts et al. Jul 2003 B2
6723071 Gerdts et al. Apr 2004 B2
6743217 Rowland et al. Jun 2004 B2
6764484 Richardson et al. Jul 2004 B2
6858034 Hijlkema et al. Feb 2005 B1
6890317 Gerdts et al. May 2005 B2
7001358 Fitzmaurice et al. Feb 2006 B2
7115109 Gerdts et al. Oct 2006 B2
7468053 Gerdts et al. Dec 2008 B2
7550002 Goto et al. Jun 2009 B2
7815601 Jordan et al. Oct 2010 B2
20020029076 Yee Mar 2002 A1
20040093061 Acosta et al. May 2004 A1
20050085891 Goto et al. Apr 2005 A1
20050085892 Goto et al. Apr 2005 A1
20060276873 Sato Dec 2006 A1
20070282436 Pinchuk Dec 2007 A1
20070293929 Aoba Dec 2007 A1
20080167628 Li et al. Jul 2008 A1
20080300667 Hebert et al. Dec 2008 A1
20090105808 Gerdts et al. Apr 2009 A1
20090254165 Tabor et al. Oct 2009 A1
20090312829 Aoba et al. Dec 2009 A1
20110264203 Dwork et al. Oct 2011 A1
20110301702 Rust Dec 2011 A1
20110313404 Amos et al. Dec 2011 A1
20120095544 Jeffrey Apr 2012 A1
20120203325 Weisman et al. Aug 2012 A1
20130274870 Lombardi Oct 2013 A1
Foreign Referenced Citations (50)
Number Date Country
620320 Feb 1992 AU
1112119 Nov 1981 CA
3345612 Jun 1985 DE
3919740 Dec 1990 DE
41 15 007 Nov 1992 DE
0 328 760 Aug 1989 EP
0 388 112 Sep 1990 EP
0 405 831 Jan 1991 EP
0 505 686 Sep 1992 EP
0 513 818 Nov 1992 EP
0 792 657 Sep 1997 EP
0 801 955 Oct 1997 EP
1 059 954 Dec 2000 EP
1 066 080 Jan 2001 EP
1 156 847 Nov 2001 EP
1867305 Dec 2007 EP
2067454 Jun 2009 EP
2133043 Dec 2009 EP
2018600 Oct 1979 GB
7-47133 Feb 1995 JP
WO 9200775 Jan 1992 WO
WO 9203963 Mar 1992 WO
WO 9213589 Aug 1992 WO
WO 9217236 Oct 1992 WO
WO 9222345 Dec 1992 WO
WO 9300126 Jan 1993 WO
WO 9311826 Jun 1993 WO
WO 9317750 Sep 1993 WO
WO 9320882 Oct 1993 WO
WO 9403213 Feb 1994 WO
WO 9404216 Mar 1994 WO
WO 9411038 May 1994 WO
WO 9411047 May 1994 WO
WO 9415549 Jul 1994 WO
WO 9633764 Oct 1996 WO
WO 9810820 Mar 1998 WO
WO 9810821 Mar 1998 WO
WO 9908740 Feb 1999 WO
WO 9938557 Aug 1999 WO
WO 9944667 Sep 1999 WO
WO 9948552 Sep 1999 WO
WO 9949808 Oct 1999 WO
WO 9959664 Nov 1999 WO
WO 0069498 Nov 2000 WO
WO 0069499 Nov 2000 WO
WO 0069500 Nov 2000 WO
WO 0147591 Jul 2001 WO
WO 02074378 Sep 2002 WO
WO 2005053574 Jun 2005 WO
WO 2011035318 Mar 2011 WO
Non-Patent Literature Citations (3)
Entry
US 5,171,298 A, 12/1992, Walker et al. (withdrawn)
Knecht, Gregory L., M.D. et al., “Double-Channel Fistulotome for Endoscopic Drainage of Pancreatic Pseudocyst”, Gastrointestinal Endoscopy, vol. 37, No. 3, May/Jun. 1991, pp. 356-357.
Siegel, Jerome H., M.D. et al., “Two New Methods for Selective Bile Duct Cannulation and Sphincterotomy”, Gastrointestinal Endoscopy, vol. 33, No. 6, Dec. 1987, pp. 438-440.
Related Publications (1)
Number Date Country
20120330397 A1 Dec 2012 US
Provisional Applications (1)
Number Date Country
61501387 Jun 2011 US